GLMD
Galmed Pharmaceuticals Ltd.
0.65
2 x 0.50
2 x 0.81
bid
ask
+
0.09
16.45%
2 @ 08:24 AM
0.61 -0.04 (6.50%)
| Ytd | -13.74% | |
| 1y | -63.61% |
0.55
day range
0.72
0.41
52 week range
2.34
| Open | 0.55 | Prev Close | 0.56 | Low | 0.55 | High | 0.72 | Mkt Cap | 4.98M |
| Vol | 431.07K | Avg Vol | 3.53M | EPS | -2.39 | P/E | N/A | Forward P/E | -2.94 |
| Beta | 0.80 | Short Ratio | 0.27 | Inst. Own | 0.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 0.61 | 200-d Avg | 0.86 | 1yr Est | 12.00 |
| Income Statement | |||
| Operating Expenses | 3.04M | ||
| Research and Development Expense | 2.10M | ||
| Selling, General and Administrative Expense | 946.00K | ||
| Operating Income | -3.04M | ||
| Interest Expense | -238.00K | ||
| Net Income | -4.82M | ||
| Net Income Common Stock | -4.82M | ||
| Net Income Common Stock (USD) | -4.82M | ||
| Consolidated Income | -4.82M | ||
| Earnings per Basic Share | -0.92 | ||
| Earnings per Basic Share (USD) | -0.92 | ||
| Earnings per Diluted Share | -0.92 | ||
| Earning Before Interest & Taxes (EBIT) | -5.06M | ||
| Earning Before Interest & Taxes (USD) | -5.06M | ||
| Weighted Average Shares | 4.31M | ||
| Weighted Average Shares Diluted | 4.31M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.11M | ||
| Cash and Equivalents (USD) | 4.11M | ||
| Investments | 14.17M | ||
| Investments Current | 14.17M | ||
| Trade and Non-Trade Receivables | 347.00K | ||
| Current Assets | 18.63M | ||
| Total Assets | 18.63M | ||
| Current Liabilities | 2.85M | ||
| Total Liabilities | 2.85M | ||
| Accumulated Retained Earnings (Deficit) | -210.78M | ||
| Accumulated Other Comprehensive Income | -303.00K | ||
| Shareholders Equity | 15.78M | ||
| Shareholders Equity (USD) | 15.78M | ||
| Trade and Non-Trade Payables | 2.85M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 1.19M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 671.00K | ||
| Issuance (Purchase) of Equity Shares | 1.19M | ||
| Net Cash Flow from Investing | 1.43M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 1.43M | ||
| Net Cash Flow from Operations | -1.94M | ||
| Share Based Compensation | 240.00K | ||